CVRx outlines $63M-$67M 2026 revenue target as Barostim adoption accelerates with new CPT code (NASDAQ:CVRX)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...